Topics:

Rheumatoid Arthritis

As your colleagues in joint surgery gathered in New Orleans last week for their annual meeting, Rheumatology Network was watching for news of special interest to you and your patients. See what we found:

How Gender, Age, Bone Strength Predict TKA Failures

The Telltale Signs of Acute Rheumatic Fever

Other Measures Outrace DASH in Assessing Hand Disability

(... and more if you click on the headline above.)

Rheumatoid Arthritis

HAQ, CDAI, RAPID3, DAS28: Which outcome measure should you use to track progress in patients with rheumatoid arthritis? Here, a brief review of their differences, and the arguments for a new paradigm in disease assessment.

The best news for rheumatologists from last year, in this review, involved osteoarthritis, psoriatic arthritis, and rheumatoid arthritis -- including a good way to assess cardiovascular risk in RA.

Soumya Raychaudhuri MD

(ACR Pediatrics 2014) How will the hundreds of new genetic biomarkers being found in rheumatology help us to untangle the web of complex diseases? In a brief podcast, a specialist in both rheumatology and genetics discusses recent and future progress.

Autoimmune disorders including rheumatoid arthritis and lupus more than triple the risk of epilepsy in young patients. Early treatment of a rheumatic condition reduces the epilepsy risk, a large study finds.

An online decision tool helped two-thirds of rheumatoid arthritis patients decide whether to take methotrexate. But when it contradicted their preconceptions, it created conflict and delays.

A study of rituximab use for rheumatoid arthritis in clinical practices in Germany finds efficacy similar to clinical trial results, plus no age-related differences and a biomarker for good outcomes.

A genetic study has found exactly how ACPA-positive and ACPA-negative rheumatoid arthritis differ, with implications for management.

Pages

Subscribe to
Please Wait 20 seconds or click here to close